Rapport Therapeutics Inc. Common Stock (RAPP)

Stock · NASDAQ · Health Care

$48.77as of 8/28/2026

Price chart

Insider transactionsShow all transaction typesRevenue Growth

No technical signal is currently active for this symbol.

Support level

$36.52

Industry

Biotechnology: Pharmaceutical Preparations

Chosen by industry and closest market cap.

RAPP
Rapport Therapeutics Inc. Common Stock
$48.77
▼ 4.05%
Market cap $1.95BP/E —
ZBIO
Zenas BioPharma Inc. Common Stock
$31.29
▼ 4.08%
Market cap $1.97BP/E —
$13.5$44.6
AUPH
Aurinia Pharmaceuticals Inc Ordinary Shares
$16.3
▼ 1.09%
Market cap $1.89BP/E 6.39
$10.34$19.25
BHVN
Biohaven Ltd. Common Shares
$15.42
▼ 4.37%
Market cap $2.01BP/E —
$7.48$18.57
NBTX
Nanobiotix S.A. American Depositary Shares
$41.28
▼ 8.59%
Market cap $1.88BP/E —
$7.02$47.66
URGN
UroGen Pharma Ltd. Ordinary Shares
$43.61
▼ 4.15%
Market cap $1.88BP/E —
$15.86$50.81
STOK
Stoke Therapeutics Inc. Common Stock
$31.61
▼ 3.01%
Market cap $1.84BP/E —
$18.8$40.22

Symbol	Market cap	P/E ratio	Price	1D	52-week range
RAPP Rapport Therapeutics Inc. Common Stock	$1.95B	—	$48.77	▼ 4.05%
ZBIO Zenas BioPharma Inc. Common Stock	$1.97B	—	$31.29	▼ 4.08%	$13.5$44.6
AUPH Aurinia Pharmaceuticals Inc Ordinary Shares	$1.89B	6.39	$16.3	▼ 1.09%	$10.34$19.25
BHVN Biohaven Ltd. Common Shares	$2.01B	—	$15.42	▼ 4.37%	$7.48$18.57
NBTX Nanobiotix S.A. American Depositary Shares	$1.88B	—	$41.28	▼ 8.59%	$7.02$47.66
URGN UroGen Pharma Ltd. Ordinary Shares	$1.88B	—	$43.61	▼ 4.15%	$15.86$50.81
STOK Stoke Therapeutics Inc. Common Stock	$1.84B	—	$31.61	▼ 3.01%	$18.8$40.22

P/E shows — for peers not currently carrying a live signal of their own.

March 31, 2026

Top holders this quarter

See the full, filterable feed with live charts on the MarketWall dashboard.